Below is a summary assembled by the Research & Innovation Office (RIO). Please see the Tang Prize website for complete information. The Tang Prize comprises four categories, namely Sustainable ...
Safety and efficacy of two candidates are currently being assessed in investigator-initiated clinical trials. BRC is planning to commence enrollment for Phase 2 and 3 trials by mid 2026. MONTEREY, ...
DURHAM, N.C. & CARLSBAD, Calif.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Argonaut Manufacturing ...
In process monitoring is important for optimizing cell culture conditions such as nutrient concentrations, cell viability, and metabolite production as well as product quality attributes such as ...
Solubility is fundamental in successfully developing all classes of therapeutic biopolymers. Contact with stressors related to mechanical stirring or changes in buffer conditions may cause ...
Hong Kong-listed Sino Biopharmaceutical said on Tuesday it would acquire China-based Hangzhou Hygieia Biomedical for up to 1.20 billion yuan ($172.04 million), as it looks to bolster its portfolio of ...
PRINCETON, N.J. and HANGZHOU, China, Dec. 28, 2025 (GLOBE NEWSWIRE) -- Transcenta Holding Limited (HKEX: 06628) (“Transcenta Therapeutics”), a global clinical stage biopharmaceutical company with ...
National Resilience, a biopharmaceutical development and manufacturing firm, has entered an agreement with Lifera, owned by a private investment fund, to develop biopharmaceutical production in Riyadh ...
Mycoplasma testing is a crucial component of quality control in cell therapy studies. In clinical applications, such as those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback